Get started
Award

70-2892-br I, 106332, 108253, 108419

Funded outputs count: 67
Funder award ID: 70-2892-BR I, 106332, 108253, 108419
OpenAlex ID: G50174683
Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer
2026 · Billaud, Amandine, Figlioli, Gisella, et al. · Apollo (University of Cambridge)
PRANA: A Deep Learning Method for Adapting Polygenic Risk Scores to Diverse Ethnic Groups
2026 · Hagai Levi, Qin Wang, et al. · medRxiv
PDF
Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer
2025 · Amandine Billaud, Gisella Figlioli, et al. · The Breast · 2
PDF
Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification
2025 · Maria Zanti, Denise G. O’Mahony, et al. · Nature Communications · 11
PDF
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis
2024 · Castelao, J.E., Geisler, J., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment
2024 · Koutros, S., Janni, W., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancer
2023 · Katharina Wichert, Reiner Hoppe, et al. · European Journal of Epidemiology · 8
PDF
A Likelihood Ratio Approach for Utilizing Case-Control Data in the Clinical Classification of Rare Sequence Variants: Application to BRCA1 and BRCA2
2023 · Maria Zanti, Denise G. O'Mahony, et al. · Human Mutation · 6
A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry
2023 · Pooja Middha, Xiaoliang Wang, et al. · Breast Cancer Research · 13
PDF
Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel
2023 · Hagai Levi, Shai Carmi, et al. · Journal of Medical Genetics · 4
PDF
Association of the CHEK2 c. 1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival
2023 · Anna Morra, Maartje A. C. Schreurs, et al. · Cancer Medicine · 11
PDF
Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases
2023 · Gisella Figlioli, Amandine Billaud, et al. · Cancers · 1
PDF
The impact of coding germline variants on contralateral breast cancer risk and survival
2023 · Anna Morra, Nasim Mavaddat, et al. · The American Journal of Human Genetics · 26
PDF
FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women
2023 · Gisella Figlioli, Amandine Billaud, et al. · European Journal of Human Genetics · 15
Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival
2023 · Josephine M.N. Lopes Cardozo, Irene L. Andrulis, et al. · Journal of Clinical Oncology · 28
PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients
2022 · Daniele Giardiello, Maartje J. Hooning, et al. · Breast Cancer Research · 22
PDF
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study
2022 · Suzanne C Dixon-Suen, Sarah J Lewis, et al. · British Journal of Sports Medicine · 87
Incorporating progesterone receptor expression into the PREDICT breast prognostic model
2022 · Isabelle Grootes, Renske Keeman, et al. · European Journal of Cancer · 20
PDF
PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~200,000 patients
2022 · Daniele Giardiello, Maartje J Hooning, et al. · Research Square · 1
PDF
Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women
2022 · Xiaoliang Wang, Pooja Middha Kapoor, et al. · Scientific Reports · 6
PDF
Rare germline copy number variants (CNVs) and breast cancer risk
2022 · Joe Dennis, Jonathan P. Tyrer, et al. · Communications Biology · 15
PDF
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis
2021 · Maria Escala-Garcia, Sander Canisius, et al. · Scientific Reports · 5
PDF
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment
2021 · Anna Morra, Maria Escala-Garcia, et al. · Breast Cancer Research · 22
PDF
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.
2021 · Morra, Anna, Escala-Garcia, Maria, et al. · Apollo (University of Cambridge)
PDF
Mendelian randomisation study of smoking exposure in relation to breast cancer risk
2021 · Hanla A. Park, Sonja Neumeyer, et al. · British Journal of Cancer · 22
PDF
Year
Topic